Edition:
United States

Medical Equipment, Supplies & Distribution

Page 2

Cardiovascular Systems announces anticipated revenue impact from hurricanes

Monday, 18 Sep 2017 07:00am EDT

Sept 18 (Reuters) - Cardiovascular Systems Inc :Cardiovascular Systems announces anticipated revenue impact from hurricanes Harvey and Irma.Cardiovascular Systems - ‍impact of hurricanes Harvey and Irma on procedure volumes in Greater Houstonm Florida will reduce fiscal 2018 Q1 revenues​.Cardiovascular Systems -‍potential revenue impact on CSI quarterly results magnified due to "small product portfolio and location and timing of storms"​.Cardiovascular Systems - ‍fiscal Q1 revenues are more heavily weighted in September, as procedure volumes begin to accelerate from summer levels​.Cardiovascular Systems Inc - ‍"Houston and Florida markets typically generate over 15% of CSI's revenues"​.Cardiovascular Systems - ‍co anticipates that the factors will reduce Q1 revenues below range of $52.6 million to $53.6 million provided on August 2, 2017​.

T2 Biosystems announces pricing of public offering of common stock

Friday, 15 Sep 2017 08:20am EDT

Sept 15 (Reuters) - T2 Biosystems Inc :T2 Biosystems announces pricing of public offering of common stock.Says public offering of 4.38 million common shares priced at $4 per share.

Soleno Therapeutics presents updated safety and efficacy data from clinical trial of DCCR for treatment of Prader-Willi syndrome

Friday, 15 Sep 2017 08:00am EDT

Sept 15 (Reuters) - Soleno Therapeutics Inc :Soleno Therapeutics presents updated safety and efficacy data from clinical trial of DCCR for treatment of Prader-Willi syndrome.Soleno Therapeutics Inc - phase iii study expected to begin by end of 2017.

Wuhan Thalys Medical Technology to invest 3.1 mln yuan into Wuhan trading firm for 51 pct stake

Friday, 15 Sep 2017 01:10am EDT

Sept 15 (Reuters) - Wuhan Thalys Medical Technology Inc <603716.SS> ::* Says it plans to boost capital of 3.1 million yuan into a Wuhan-based trading firm, in exchange for 51 percent stake .

Maccura Biotechnology to invest 10 mln yuan to set up biotech unit in Shanghai

Thursday, 14 Sep 2017 10:11pm EDT

Sept 15(Reuters) - Maccura Biotechnology Co Ltd <300463.SZ>:Says it plans to invest 10 million yuan to set up a wholly owned biotechnology unit in Shanghai.

Lightpath Technologies Q4 revenue rose 90 pct to $9 mln

Thursday, 14 Sep 2017 04:55pm EDT

Sept 14 (Reuters) - Lightpath Technologies Inc :Q4 revenue rose 90 percent to $9.0 million.Lightpath Technologies Inc qtrly earnings per share $0.24.Lightpath Technologies Inc - 12-month backlog was approximately $9.3 million at June 30, 2017, as compared to $6.6 million at June 30, 2016.

LivaNova ‍expects to achieve revenue growth in mid-single-digits in near term and high-single-digits in long term​

Thursday, 14 Sep 2017 04:27pm EDT

Sept 14 (Reuters) - LivaNova Plc :LivaNova Plc - ‍Expects to achieve revenue growth in mid-single-digits in near term and high-single-digits in long term​.LivaNova Plc - ‍Anticipates compounded annual earnings per share growth in low- to mid-teens from 2017 to 2022​.

T2 Biosystems announces proposed public offering of common stock

Thursday, 14 Sep 2017 04:11pm EDT

Sept 15 (Reuters) - T2 Biosystems Inc :T2 Biosystems announces proposed public offering of common stock.

Euromedis Groupe FY revenue rises to 73.6‍​ million euros

Thursday, 14 Sep 2017 12:34pm EDT

Sept 14 (Reuters) - EUROMEDIS GROUPE SA ::FY REVENUE EUR 73.6‍​ MILLION VERSUS EUR 73.2 MILLION YEAR AGO.EXPECTS FY REVENUE FOR 2017/2018 OF EUR 80 MLN.‍​.

Spineguard operating loss narrows to 1.5 million euros

Thursday, 14 Sep 2017 12:01pm EDT

Sept 14 (Reuters) - SPINEGUARD SA ::SPINEGUARD REPORTS SIX-MONTH 2017 FINANCIAL RESULTS.H1 NET LOSS EUR ‍​2.2 MILLION VERSUS LOSS OF EUR 2.5 MILLION YEAR AGO.H1 ‍OPERATING LOSS IMPROVES BY 31% AND REDUCES TO EUR 1.5M​.H1 REVENUE EUR ‍​4.2 MILLION VERSUS EUR 3.6 MILLION YEAR AGO.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary